Sentinel node biopsy in male breast cancer

European Journal of Surgical Oncology

Volumn 25, Issue 4, 1999, Pages 442-443

  Hill, A D K ^a   Borgen, P I ^a   Cody III, H S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CASE REPORT; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MALE; MALE BREAST; PRIORITY JOURNAL;

EID: 0033179756     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0674     Document Type: Article

References (12)

1. Boring CC, Squires TS, Tong T. Cancer statistics, 1994. CA 1994; 44: 7-26.
2. Guiliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
3. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-40.
4. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes. Lancet 1997; 349: 1864-7.
5. Petrek JA, Blackwood MM. Axillary dissection: Current practice and technique. Curr Prob Surg 1995; XXXII: 309-16.
6. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: The initial experience at Memorial Sloan Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7.
7. Fisher B, Ravdin RG, Ausman RK, et al. Surgical adjuvant chemotherapy in cancer of the breast; results of a decade of cooperative investigation. Ann Surg 1968; 168: 337.
8. Bonnadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-positive breast cancer. N Engl J Med 1995; 332: 901-6.
9. Borgen PI, Wong GY, Vlamis V, et al. Current management of male breast cancer, a review of 104 cases. Ann Surg 1994; 215: 451-9.
10. Anelli A, Anelli TFM, Youngson B, Rosen PP, Borgen PI. Mutations of the p53 gene in male breast cancer. Cancer 1995; 75: 2233-8.
11. Borgen PI. Male breast cancer. Semin Surg Oncol 1991; 7: 314-9.
12. Anelli TFM, Anelli A, Tran KN, Lebwohl DE, Borgen PI. Tamoxifen administration is associated with a high rate of treatment limiting symptoms in male breast cancer patients. Cancer 1994; 74: 74-7.